Calcium and bone turnover markers in acromegaly: A prospective, controlled study

42Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Context: Acromegaly has been associated with calcium-phosphate and bone turnover alterations. Controlled studies of these interactions are sparse. Objective: To evaluate calcium and bone metabolism in active and treated acromegaly. Design/Setting/Patients: We conducted a controlled, prospective study at a tertiary referral center. We studied 22 patients with acromegaly referred for surgical or medical therapy (ACM) and 22 with nonfunctioning pituitary adenomas referred for surgery (control). Main OutcomeMeasures: Calcium(serum and urine), phosphorus, parathyroid hormone (PTH), 25-hydroxyand 1,25-dihydroxy-Vitamin D, bone turnover markers [serum C-terminal telopeptide of type 1 collagen (CTX) and procollagen type 1 N-terminal propeptide (P1NP)], and cytokines [receptor activator of nuclear factor kB ligand (RANK-L) and osteoprotegerin (OPG)] at baseline and 3 to 6 months after treatment. Results: At baseline, the ACM group had lower PTH levels than controls (36.3613.9 pg/mL vs 56.06 19.9 pg/mL) and higher phosphorus (4.34 6 0.71 mg/dL vs 3.55 6 0.50 mg/dL) (P < 0.01). Groups had similar levels of serum and urine calcium and 25-hydroxy-and 1,25-dihydroxy-Vitamin D. The ACM group had higher bone turnover markers than control; P1NP and CTX were strongly correlated (r2 = 0.82, P,0.05). CTX was dependent on age and disease group but not on sex or gonadal status. After treatment of acromegaly, serum calcium (9.52 6 0.43 mg/dL to 9.26 6 0.28 mg/dL), phosphorus (4.34 6 0.71 mg/dL to 3.90 6 0.80 mg/dL), and CTX (0.91 6 0.75 ng/mL to 0.63 6 0.68 ng/mL) decreased, while PTH increased (36.3 6 13.9 pg/mL to 48.9 6 16.7 pg/mL) (P < 0.01). 25-hydroxy-Vitamin D, P1NP, and RANK-L/OPG ratio did not change significantly. Conclusion: Acromegaly patients exhibited PTH-independent calcium-phosphate alterations andenhanced coupled bone formation and resorption. Within 6 months of treatment, bone resorption decreased, whereas RANK-L/OPG changeswere inconsistent.

Cite

CITATION STYLE

APA

Constantin, T., Tangpricha, V., Shah, R., Oyesiku, N. M., Ioachimescu, O. C., Ritchie, J., & Ioachimescu, A. G. (2017). Calcium and bone turnover markers in acromegaly: A prospective, controlled study. Journal of Clinical Endocrinology and Metabolism, 102(7), 2416–2424. https://doi.org/10.1210/jc.2016-3693

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free